National Bank of Canada’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8
Closed -$125 3188
2025
Q3
$125 Sell
8
-31
-79% -$640 ﹤0.01% 2762
2025
Q2
$773 Hold
39
﹤0.01% 2731
2025
Q1
$688 Hold
39
﹤0.01% 2613
2024
Q4
$1.8K Buy
39
+8
+26% +$338 ﹤0.01% 2592
2024
Q3
$939 Hold
31
﹤0.01% 2434
2024
Q2
$491 Sell
31
-1
-3% -$16 ﹤0.01% 2567
2024
Q1
$463 Hold
32
﹤0.01% 2604
2023
Q4
$543 Hold
32
﹤0.01% 2586
2023
Q3
$572 Hold
32
﹤0.01% 2644
2023
Q2
$361 Hold
32
﹤0.01% 2638
2023
Q1
$373 Buy
+32
New +$446 ﹤0.01% 2606

Other funds holding TECX

National Bank of Canada's TECX Position: Q4 2025 in Review

National Bank of Canada sold out of Tectonic Therapeutic (TECX) in Q4 2025, closing a stake of 8 shares — an estimated $125 sold.

National Bank of Canada first reported a position in TECX in Q1 2023 and held it in 11 quarters. The position peaked at $1.8K in Q4 2024. 105 funds tracked by Wall St. Rank hold TECX as of Q4 2025.

  • National Bank of Canada reported no remaining Tectonic Therapeutic position as of Q4 2025 after selling out during the quarter.
  • National Bank of Canada sold 8 Tectonic Therapeutic shares in Q4 2025, an estimated $125.
  • National Bank of Canada first reported a position in Tectonic Therapeutic in Q1 2023 and held it in 11 quarters.
  • National Bank of Canada's Tectonic Therapeutic position peaked at $1.8K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.